An intriguing association between dental and mental pathology in addicted and control subjects: A cross-sectional survey

British Dental Journal

Volumn 205, Issue 11, 2008, Pages

  Reece, A S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ADDICTION; ADOLESCENT; ADULT; AGGRESSION; AGING; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CANNABIS ADDICTION; CLASSIFICATION; CROSS-SECTIONAL STUDY; DEPRESSION; DRINKING BEHAVIOR; DRUG ABUSE; EPILEPSY; FEMALE; HEROIN DEPENDENCE; HUMAN; MALE; MENTAL DEFICIENCY; MENTAL DISEASE; MIDDLE AGED; MORPHINE ADDICTION; PHYSIOLOGY; PSYCHOSIS; SCHIZOPHRENIA; SMOKING; STEM CELL; TOOTH DISEASE;

ADOLESCENT; ADULT; AGGRESSION; AGING; ALCOHOL DRINKING; AMPHETAMINE-RELATED DISORDERS; ANXIETY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; DEPRESSION; EPILEPSY; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; MARIJUANA ABUSE; MENTAL DISORDERS; MENTAL RETARDATION; METHADONE; MIDDLE AGED; MORPHINE DEPENDENCE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SMOKING; STEM CELLS; SUBSTANCE-RELATED DISORDERS; TOOTH DISEASES; YOUNG ADULT;

EID: 57649178886     PISSN: 00070610     EISSN: 17417503     Source Type: Journal    
DOI: 10.1038/sj.bdj.2008.932     Document Type: Review

References (98)

1. Desvarieux M, Demmer R T, RundekT et al. Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 2005; 111:576-582.
2. Grau A J, Becher H, Ziegler C M et al. Periodontal disease as a risk factor for ischemic stroke. Stroke 2004; 35:496-501.
3. Joshipura KJ, Hung H C, Rimm E B, Willett W C, Ascherio A. Periodontal disease, tooth loss, and incidence of ischemic stroke. Stroke 2003; 34:47-52.
4. Mattila K J. Dental infections as a risk factor for acute myocardial infarction. Eur Heart J 1993; 14(Suppl K): 51-53.
5. Mattila K J, Valle M S, Nieminen M S, Valtonen V V, Hietaniemi K L. Dental infections and coronary atherosclerosis. Atherosclerosis 1993; 103:205-211.
6. Desvarieux M, Demmer R T, Rundek T et al. Relationship between periodontal disease, tooth loss, and carotid artery plaque: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Stroke2003; 34: 2120-2125.
7. Espinola-Klein C, Rupprecht H J, Blankenberg S et al. Impact of infectious burden on progression of carotid atherosclerosis. Stroke 2002; 33: 2581-2586.
8. Espinola-Klein C, Rupprecht H J, Blankenberg S et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 2002; 105: 15-21.
9. Kiechl S, Egger G, Mayr M et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001; 103: 1064-1070.
10. Papapanou P N, Neiderud A M, Papadimitriou A, Sandros J, Dahlen G. "Checkerboard" assessments of periodontal microbiota and serum antibody responses: a case-control study. J Periodontal 2000;71:885-897.
11. Slade G D, Ghezzi E M, Heiss G, Beck J D, Riche E, Offenbacher S. Relationship between periodontal disease and C-reactive protein among adults in the Atherosclerosis Risk in Communities study. Arch intern Med 2003; 163:1172-1179.
12. Ebersole J L, Machen R L, Steffen M J, Willmann D E. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol 1997; 107:347-352.
13. Wu T, Trevisan M, Genco R J, Dorn J P, Falkner K L, Sempos C T. Periodontal disease and risk of cerebrovascular disease: the first national health and nutrition examination survey and its follow-up study. Arch Intern Med 2000; 160: 2749-2755.
14. Kirkpatrick B, Hack G D, Higginbottom E, Hoffacker D, Fernandez-Egea E. Palate and dentition in schizophrenia. Schizophr Res 2007; 91: 187-191.
15. Kirkpatrick B, Messias E, Harvey P D, Fernandez- Egea E, Bowie C R. Is schizophrenia a syndrome of accelerated aging? Schizophr Bull 2007 Dec 21 [Epub ahead of print].
16. United Nations Office of Drugs and Crime. World drug report 2007. Vienna: UN ODC, 2007.
17. UNAIDS. 2006 report on the global AIDS epidemic. Geneva: UNAIDS, 2007.
18. Gottschalk LA, McGuire F L, Heiser J F, Dinovo E C, Birch H. Drug abuse deaths in nine cities: a survey report. Rockville, MD, USA: National Institutes on Drug Abuse, 1979. NIDA Research Monograph 29.
19. Lombard D B, Chua K F, Mostoslavsky R, Franco S, Gostissa M, Alt F W. DNA repair, genome stability, and aging. Cell 2005;120:497-512.
20. Gronbladh L, Gunne L. Methadone-assisted rehabilitation of Swedish heroin addicts. Drug Alcohol Depend 1989; 24: 31-37.
21. Hser Y I, Hoffman V, Grella C E, Anglin M D. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry 2001; 58: 503-508.
22. Gronbladh L, Ohlund LS, Gunne L M. Mortality in heroin addiction: impact of methadone treatment. ,Aera Psychiatr Scand 1990; 82 : 223-227.
23. Gunne L M, Gronbladh L. The Swedish methadone maintenance program: a controlled study. Drug Alcohol Depend 1981; 7: 249-256.
24. Poser W, Koc J, Ehrenreich H. Methadone maintenance treatment. Methadone treatment can reduce mortality. BMJ 1995; 310:463.
25. Darke S. Degenhardt L, Mattick R. Mortality amongst illicit drug users: epidemiology causes and intervention. Cambridge: Cambridge University Press, 2007.
26. Reece A S. Chronology and patterns of psychiatric morbidity in substance dependent and medical patients. AustraiasPsychiatry 2008; In Press.
27. Darke S, Kaye S, Duflou J. Systemic disease among cases of fatal opioid toxicity. Addiction 2006; 101: 1299-1305.
28. Hulse G K, English D R, Milne E, Holman C D. The quantification of mortality resulting from the regular use of illicit opiates. Addiction 1999; 94: 221-229.
29. Zagon I S, Verderame M F, McLaughlin P J. The biology of the opioid growth factor receptor (OGFr). Brain ResBrain Resfiev 2002; 38:351-376.
30. Mao J, Sung B, Ji R R, Lim G. Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism. J Neurosci 2002; 22: 7650-7661.
31. Maccarrone M, Lorenzon T, Bari M, Melino G, Finazzi-Agro A. Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J Biol Chem 2000; 275: 31938-31945.
32. Bari M, Battista N, Fezza F, Finazzi-Agro A, Maccarrone M. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. J Biol Chem 2005; 280: 12212-12220.
33. Krasnova I N, Ladenheim B, Cadet J L. Ampheta mine induces apoptosis of medium spiny striatal projection neurons via the mitochondria-dependent pathway. FASEBJ 2005; 19: 851-853.
34. Li G, Xiao Y, Zhang L. Cocaine induces apoptosis in fetal rat myocardial cells through the p38 mitogen-activated protein kinase and mitochon drial/cytochrome c pathways. J Pharmacol Exp Ther 2005; 312: 112-119.
35. Hadley E C, Lakatta E G, Morrison-Bogorad M, Warner H R, Hodes R J. The future of aging thera pies. Cell 2005; 120: 557-567.
36. Kirkwood T B. Understanding the odd science of aging. Ce// 2005; 120: 437-447.
37. Rossi D J, Bryder D, Zahn J M et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Nati Acad Sci USA 2005; 102: 9194-9199.
38. Schlessinger D, Van Zant G. Does functional depletion of stem cells drive aging? Mech Ageing Dev 2001;122:1537-1553.
39. Bryder D, Rossi D J, Weissman I L. Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol 2006; 169:338-346.
40. Rando T A. Stem cells, ageing and the quest for immortality. Nature 2006; 441: 1080-1086.
41. Reece A S. Hair graying in substance addiction. Arch Dermatol 2007; 143: 116-118.
42. Nishimura E K, Jordan S A, Oshima H et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature 2002; 416: 854-860.
43. Steingrimsson E, Copeland N G, Jenkins N A. Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet 2004; 38:365-411
44. Steingrimsson E, Copeland N G, Jenkins N A. Melanocyte stem cell maintenance and hair graying. Ceil 2005; 121:9-12.
45. Reece A S. Dentition of addiction in Queensland: poor dental status and major contributing drugs. Aust Dent J 2007; 52: 144-149.
46. Osborn M. Butler T, Barnard P D. Oral health status of prison inmates - New South Wales, Australia. Aust Dent J 2003; 48: 34-38.
47. Kim T W, Alford D P, Malabanan A, Holick M F, Samet J H. Low bone density in patients receiving methadone maintenance treatment. Drug Alcohol Depend 2006; 85: 258-262.
48. Idris A l.van't Hof R J, Greig I R et al. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat Med 2005; 11: 774-779.
49. Australian Institute of Health and Welfare. National comorbidity initiative: a review of data collections relating to people with coexisting substance use and mental health disorders. Canberra: AIHW, 2005.
50. Huang H FS, Nahas G G, Hembree W C III. Effects of marihuana inhalation on spermatogenesis of the rat. in Nahas G G, Sutin K M, Harvey D J, Agurell S (eds) Marihuana and medicine. pp359-366. Totowa, New Jersey: Humana Press, 1999.
51. Hembree W C III, Nahas G G, Zeidenberg P, Huang HPS. Changes in human spermatozoa associated with high dose marihuana smoking, In Nahas G G, Sutin K M, Harvey D J, Agurell S (eds) Marihuana and medicine, pp 367-378. Totowa, New Jersey: Humana Press, 1999.
52. Reece AS, Davidson P. Deficit of circulating stem- progenitor cells in opiate addiction: a pilot study. Subst Abuse Treat Prev Policy 2007; 2: 19.
53. Reece A. Lifetime prevalence of cervical neoplasia in addicted and medical patients. Aust NZJ Obstet Gynaecol 2007; 47: 419-423.
54. Sidney S, Quesenberry C P Jr, Friedman G D, Tekawa I S. Marijuana use and cancer incidence (California, United States). Cancer Causes Control 1997; 8: 722-728.
55. Reece AS. Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers. lmmun Ageing 2007; 4: 6.
56. Huang G T. A paradigm shift in endodontic management of immature teeth: conservation of stem cells for regeneration. J Dent 2008; 36:379-386.
57. Tonetti M S, D'Aiuto F, Nibali L et al. Treatment of periodontitis and endothelial function. N Engl j Med 2007; 356: 911-920.
58. National Institute of Dental and Craniofacial Research. Webpage: Looking at the periodon- tal-systemic disease connection. Inside Scoop, July 2005. http://www.nidcr.nih.gov/Research/ResearehResults/lnterviewsOHR/TIS072005.htm (accessed 9 October 2008).
59. Andl T, Ahn K, Kairo A et al. Epithelial Bmprla regulates differentiation and proliferation in postnatal hair follicles and is essential for tooth development. Development 2004; 131: 2257-2268.
60. lohara K, Nakashima M, Ito M, Ishikawa M, Nakasima A, Akamine A. Dentin regeneration by dental pulp stem cell therapy with recombinant human bone morphogenetie protein 2. J Dent Res 2004; 83: 590-595.
61. Nakashima M, lohara K, Ishikawa M et al. Stimulation of reparative dentin formation by ex vivo gene therapy using dental pulp stem cells electrotransfected with growth/differentiation factor 11 (Gdf11). Hum Gene Ther 2004; 15: 1045-1053.
62. Ohazama A, Modino S A, Miletich I, Sharpe P T. Stem-cell-based tissue engineering of murine teeth. J Dent Res 2004; 83: 518-522.
63. Kung C. A possible unifying principle for mechanosensation. Nature 2005; 436: 647-654.
64. Seo B M, Miura M, Gronthos S et al. Investigation of multipotent postnatal stem cells from human periodontal ligament, Lancet2004; 364:149-155.
65. Wojciak-Stothard B, Torondel B, Tsang LY et al. The ADMA/DDAH pathway is a critical regulator of endothelial cell motility. J CeilSci 2007; 120:929-942.
66. Kidd E A M. Joyston-Bechal S. Essentials of dental caries. The disease and its management. 2nd ed. Oxford: Oxford University Press, 2002.
67. National Institute of Dental and Craniofacial Research. Periodontal (gum) disease. Bethesda, MD: NIDCR, 2004.
68. National Institute of Dental and Craniofacial Research website. Oral complications of systemic diseases webpage. http://www.nidcr.nih.gov/Oral- Health/Oral Health Information/System icDiseases/ (accessed 9 October 2008).
69. Drapeau E, Mayo W, Aurousseau C, Le Moal M, Piazza P V, Abrous D N. Spatial memory performances of aged rats in the water maze predict levels of hippoeampal neurogenesis. Proc Natl Acad Sci U S A2003; 100: 14385-14390.
70. Fonseca R, Nagerl U V, Morris R G, BonhoefferT. Competing for memory: hippoeampal LTP under regimes of reduced protein synthesis. Neuron 2004; 44: 1011-1020.
71. Kee N, Teixeira C M, Wang A H, Frankland P W. Preferential incorporation of adult-generated granule cells into spatial memory networks in the dentate gyrus. Nat Neurosci 2007; 10:355-362.
72. SahayA, Hen R. Adult hippoeampal neurogenesis in depression. Nat Neurosci 2007; 10: 1110-1115.
73. Perera T D, Coplan J D, Lisanby S H et ai. Antide- pressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J Neurosci 2007; 27:4894-4901.
74. Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci2007; 10: 1089-1093.
75. Gould T D, Dow E R, 0'Donnell K C, Chen G, Manji H K. Targeting signal transduction pathways in the treatment of mood disorders: recent insights into the relevance of the Wnt pathway. CNS Neurol Disord Drug Targets 2007; 6: 193-204.
76. Bao G, Kang L, Li H et ai. Morphine and heroin differentially modulate in vivo hippocampal LTP in opiate-dependent rat. Neuropsychopharmacology 2007; 32: 1738-1749.
77. Moore T H, Zammit S, Lingford-Hughes A et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319-328.
78. Nordentoft M, Hjorthoj C. Cannabis use and risk of psychosis in later life. Lancet 2007; 370: 293-294.
79. Li T K, Volkow N D, Baler R D, Egli M. The biological bases of nicotine and alcohol co-addiction. Biol Psychiatry 2007; 61: 1-3.
80. Nicolle M M, ZH-Y, Bizon J.L In Riddle D R (ed) Brain aging: models, methods and mechanisms. pp 213-228. Boca Raton, FL: CRC Press, Taylor and Francis Group, 2007.
81. Hedden T. Imaging cognition in the aging human brain. In Riddle D R (ed) Brain aging: models, methods, and mechanisms, pp 251-278. Boca Raton, FL: CRC Press, Taylor and Francis Group, 2007.
82. Riddle D R, Lichtenwalner R J. Neurogenesis in the adult and aging brain. In Riddle D R (ed) Brain aging: models, methods, and mechanisms. pp 127-158. Boca Raton, FL: CRC Press, Taylor and Francis Group, 2007.
83. Shi L, Adams M, Brunso-Bechtold J K. Subtle alterations in glutamatergic synapses underlie the aging related decline in hippoeampal function. In Riddle D R (ed) Brain aging: models, methods, and mechanisms, pp 189-212. Boca Raton, FL: CRC Press, Taylor and Francis Group, 2007.
84. Chang L, Cloak C, Patterson K, Grab C, Miller E N, Ernst T. Enlarged striatum in abstinent metham- phetamine abusers: a possible compensatory response. Biol Psychiatry 2005; 57:967-974.
85. Fowler J S, Volkow N D, Kassed C A, Chang L. Imaging the addicted human brain. SciPract Perspect 2oo7;3:4-16.
86. Jacobsen L K. Giedd J N, Gottschalk C, Kosten T R, Krystal J H. Quantitative morphology of the caudate and putamen in patients with cocaine dependence. Am J Psychiatry 2001; 158:486-489.
87. Jernigan T L, Gamst A C, Archibald S L et al. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry 2005; 162: 1461-1472.
88. Zhang R L, LeTourneau Y, Gregg S R et al. Neuroblast division during migration toward the ischemic striatums study of dynamic migratory and proliferative characteristics of neuroblasts from the subventricu- lar zone. J Neurosci 2007; 27:3157-3162.
89. YamashitaT, Ninomiya M, Hernandez Acosta P et al.Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum. J Neurosci 2006; 26: 6627-6636.
90. Nygren J, Wieloch T, Pesic J, Brundin P, Deierborg T. Enriched environment attenuates cell genesis in subventricular zone after focal ischemia in mice and decreases migration of newborn cells to the striatum. stroke 2006; 37: 2824-2829.
91. Lin J H, Takano T, Arcuino G et al. Purinergic signaling regulates neural progenitor cell expansion and neurogenesis. Dev Biol2007; 302: 356-366.
92. Corson P W, Nopoulos P, Miller D D, Arndt S,Andreasen N C. Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry 1999; 156: 1200-1204.
93. Dyer K R, White J M. Patterns of symptom complaints in methadone maintenance patients. Addiction 1997; 92: 1445-1455.
94. Schreiber S, Peles E, Adelson M. Association between improvement in depression, reduced benzodiazepine (BDZ) abuse, and increased psychotropic medication use in methadone maintenance treatment (MMT) patients. Drug Alcohol Depend 2008; 92: 79-85.
95. Berton 0, Covington H E 3rd, Ebner K et ai. Induction of deltaFosB in the periaqueductal gray by stress promotes active coping responses. Neuron 2007; 55:289-300.
96. Fitzgerald L W, Ortiz J, Hamedani A G, Nestler E J. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J Neurosci 1996; 16: 274-282.
97. Green T A, Alibhai I N, Hornmel J D et al. Induction of inducible cAMP early repressor expression in nucleus accumbens by stress or amphetamine increases behavioral responses to emotional stimuli. J Neurosci 2006; 26: 8235-8242.
98. Marsteller D A, Gerasimov M R, Schiffer W K et al. Acute handling stress modulates methylphenidate-induced catecholamine overflow in the medial prefrontal cortex. Neuropsychopharmacoiogy2002; 27: 163-170.